Skip to main content
Log in

Efficacy of Peptide Anxiolytic Selank during Modeling of Withdrawal Syndrome in Rats with Stable Alcoholic Motivation

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We studied the effects of selank on the development of symptoms of acute 48-h alcohol withdrawal in outbred rats drinking 10 % ethanol as the only source of fluid for 24 weeks. In alcohol-preferring animals (mean daily ethanol intake >5.0 g/kg) allowed free choice between 10 % ethanol and water, single intraperitoneal injection of selank in a dose of 0.3 mg/kg eliminated anxiety induced by ethanol withdrawal in tests elevated plus maze and social interaction tests and prevented the formation of mechanical allodynia without affecting ethanol consumption. The fi ndings suggest that selank is effective in eliminating of alcohol withdrawal symptoms in rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. N. V. Kossh, V. K. Meshavkin, O. Yu. Sokolov, et al., Vestn. Ross. Akad. Med. Nauk, No. 3, 24-33 (2007).

  2. A. V. Nadorova, M. M. Kozlovskaja, and S. B. Seredenin, Bull. Exp. Biol. Med., 148, No. 4, 609-611 (2009).

    Article  CAS  PubMed  Google Scholar 

  3. Narcology: National Guidance [in Russian], Eds. N. N. Ivanets, et al., Moscow (2008), pp. 199-227.

  4. L. A. Andreeva, L. Yu. Alfeeva, I. A. Grivennikov, et al., Patent of RF No. 2155065. Anxiolytic Drug and Pharmaceutical Composition of Anxiolytic Effect, Byul. Izobr., No. 24, 236 (2000).

  5. T. P. Semenova, I. I. Kozlovskii, N. M. Zakharova, and M. M. Kozlovskaya, Eksp. Klin. Farmakol., 73, No.8, 2-5, (2010)

    CAS  PubMed  Google Scholar 

  6. E. S. Teleshova, V. K. Bochkarev, T. S. Syunyakov, et al., Psikhiatriya, No.4, 26-35 (2010).

  7. T. Jukić, B. Rojc, D. Boben-Bardutzky, et al., Coll Antropol., 35, No. 4, 1225-1230 (2011).

    PubMed  Google Scholar 

  8. R. Malcolm, H. Myrick, J. Roberts, et al., J. Gen. Intern. Med., 17, No. 5, 349-355 (2002).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. D. H. Overstreet, D. J. Knapp, S. S. Moy, and G. R. Breese, Psychopharmacology, 167, No. 4, 344-352 (2003).

    CAS  PubMed Central  PubMed  Google Scholar 

  10. S. Pellow, P. Chopin, S. E. File, and M. Briley, J. Neurosci. Methods, 14, 149-167 (1985).

    CAS  Google Scholar 

  11. J. A. Shumilla, T. Liron, D. Mochly-Rosen, et al., J. Pain, 6, No. 8, 535-549 (2005).

    Article  CAS  PubMed  Google Scholar 

  12. V. B. Solov’ev, M. T. Gengin, T. N. Sollertinskaia, et al., Zh. Evol. Biokhim. Fiziol., 48, No. 3, 254-257 (2012)

    PubMed  Google Scholar 

  13. A. Urayama, K. King, F. S. Gaskin, et al., Peptides, 27, No. 9, 2201-2206 (2006).

    Article  CAS  PubMed  Google Scholar 

  14. A. N. Vernigora, Zh. S. Bardinova, V. A. Smetanin, and M. T. Gengin, Ukr. Biokhim. Zh., 76, No. 3, 68-73 (2004).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. G. Kolik.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 1567, No. 1, pp. 61-65, January, 2014

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kolik, L.G., Nadorova, A.V. & Kozlovskaya, M.M. Efficacy of Peptide Anxiolytic Selank during Modeling of Withdrawal Syndrome in Rats with Stable Alcoholic Motivation. Bull Exp Biol Med 157, 52–55 (2014). https://doi.org/10.1007/s10517-014-2490-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-014-2490-4

Keywords

Navigation